Advs. David Osborne and Ezra Gross represented the American company HelpSystems in their acquisition of the long-standing Israeli cyber company Beyond Security.
Advs. Ben Sandler, Ezra Gross, Ofir Levy, Barry Levenfeld, together with Chaim Cohen, Hadar Stein, Neta Goshen Brami and Nir Kamhi represented the US cloud security company Zscaler Inc. in its acquisition of the Israeli cloud infrastructure entitlement management company Trustdome. With this acquisition, Zscaler opens its first R&D center in Israel, where the company plans to continue investing.
Advs. Gil Oren, Micki Shapira and Michael Horowitz and intern Gabi Schickler, represented Super-Pharm (Israel's largest drug stores chain and the second largest retail chain in Israel) in a transaction in which it acquired from Teva Pharmaceuticals the full ownership of Remedix Care, a manufacturer of preparation of specialist drugs for use in hospitals and in patients' homes. The transaction completion is subject to the approval of the Israel Competition Authority.
Advs. Barry Levenfeld, Ben Sandler and David Roness together with Daniel Green, Yuval Shalheveth, Eli Greenbaum, Ofir Levy, Shani Rapoport, Miriam Friedmann, Ofir Paz, Neta Goshen Brami, Hadar Stein, Shalhevet Hetli , Sophy Litvin and Katya Kagantsov represented PayPal in the acquisition of Curv, an Israeli cryptocurrency startup for about $200 million.
Advs. Barry Levenfeld and Ben Sandler, with the assistance of Daniel Green, Shira Lahat, Shani Rapoport, Joshua Lieberman, Dr. Eran Lempert, Nir Kamhi, Miriam Friedmann, Roni Osborne, Tali Har-Oz, Chaim Cohen and intern Michael Portman served as the Israeli attorneys for Boston Scientific in a transaction to acquire the global surgical business of Lumenis for (slightly) more than $1 billion ($1.07B, to be exact).
Advs. Barry Levenfeld, together with Ben Sandler and David Roness with the assistance of Daniel Green, Ofir Levy, Shira Lahat, Shani Rapoport, Asaf Eylon, Tamar Tavory, Miriam Friedmann, Chaim Cohen, Hadar Stein, Nir Kamhi, Tali Har-Oz, Shalhevet Hetli, Lihi Katzenelson, Roni Osborne, Adi Daniel Zamir, Guy Fatal, Hadil Nassif and interns Tani Sterman, Michael Portman and Alon Shemesh represented the private equity fund Altaris Capital Partners, LLC in the acquisition of Perrigo's generic pharmaceuticals operations (including the acquisition of Perrigo's factory in Yeruham) for $1.55 billion.
Advs. Barry Levenfeld and Ben Sandler together with Ofir Levy, Eli Greenbaum, Shani Rapoport, Ofir Paz, Miriam Friedmann, Neta Goshen Brami, Chaim Cohen and Hadar Stein and interns Michael Portman and Alon Shemesh represented the global cybersecurity leader Palo Alto Networks in its acquisition of the Israeli company Bridgecrew for US200 million dollars.
Advs. Barak Platt, Shira Teger, Nimrod Vromen, Ofir Levy, Ben Sandler, Eli Greenbaum, Daniel Green, Netanella Treistman, Ofir Paz, Derora Tropp and intern Stephen Staszewski represented Cappitech in its acquisition by IHS Markit (NYSE: INFO) a world leader in critical information, analytics and solutions. IHS Markit was a customer of Capitech, and decided to acquire it. The firm has represented Capitech for a number of years, and also accompanied it in its 2018 Series A investment round. Capitech, a privately held Israeli company, provides robust regulatory reporting, best execution analysis and business intelligence solutions, and will continue to operate under IHS Markit.
Advs. Eliran Furman and Moshe Pasker and intern Dana Kleiman represented Telefire in their acquisition of Koach Bat Kol. Telefire is a leader in the fire safety sector.
Advs. Micki Shapira, Daniel Green and Sophy Litvin represented Fosun Health Fund (the venture capital arm of Fosun Pharma) in an exclusive license and supply agreement with Raziel Therapeutics to develop and commercialize Raziel's proprietary RZL-012, an injection used for reducing double chins, in mainland China, Hong Kong, Macau, and Taiwan for milestone payments of up to $74 million plus tiered royalties on future sales. The team was joined by advs. Miriam Friedmann, Inbar Hakimian-Nahari and intern Yang Cheng.